Cholangiopancreatoscopy SpyGlass-DS experience in a Spanish tertiary hospital
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S61
DOI: 10.1055/s-0044-1782816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von C. Amiama Roig und 5 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Aims
Cholangiopancreatoscopy has become an essential tool in ERCP. Our aim is to evaluate its efficacy and safety using the SpyGlass-DS device in a Spanish tertiary center.
Methods
We conducted a retrospective study including the cholangiopancreatoscopies performed between July 2016 and October 2023 in a Spanish tertiary center using the Spyglass DS/DSII systems. In addition to baseline patients characteristics we collected previous procedures,sedation,indication,procedure related variables, success and complicatons. Success was defined for lithotripsy as the ability to clear the bile duct endoscopically and for strictures as the ability to evaluate the stricture and biopsy it if needed. Benign stenosis definitive diagnosis was considered if there were no signs of malignancy/atypia in the pathological anatomy and if during follow-up of more than 6 months, there were no clinical or radiological signs of malignancy. Complications were diagnosed and graded following ESGE clinical guideline [ 1 ]
Results
124 examinations were performed on 108 patients(average age 67.7 years, SD 17.9; male/female 53.7/46.3%). 71.9% were conducted in the lateral decubitus position with sedation, and 28,1% in prone position under general anaesthesia. 95.2% were biliar and 4.8% were pancreatic. Prior procedures included sphincterotomy in 64.5% of cases, sphincteroplasty in 25%, biliary stents in 45.2%, both biliary and pancreatic stents in 8.9%, and SpyGlass examinations in 12.1%. Indications were 57.3% for stenosis, 23.4% for lithotripsy, 8.1% for the exclusion of residual stones, 4% for evaluating other intraductal lesions, 2.4% for assesing radiofrecuency ablation,and 6.4% for others. Regarding lithiasis, the location in the extrahepatic bile duct/hilum/intrahepatic/pancreatic was 71.1%/4.4%/17.8%/6.7%. Stone clearance was achieved in one session in the 79.5%, in two sessions in the 12.8% and in 3 sessions in the 7.7%. For stenosis, locations were in the extrahepatic bile duct (45.3%), hilum/intrahepatic (49.3%), and pancreas (5.3%). Biopsies were performed in 78.9% of cases. According to optical diagnosis 31.6% of the stenosis were benign, 44.7% were malignant and 23.7% indeterminate. By Histological examination 39.5% were benign, 28,9% malignant, 14,5% indeterminate and 15,8% had insufficient simples. 44.7% had a definitive benign diagnosis, 48.7% definitive malignant and 6.6% are still being monitored. The total technical success rate was 85.5%, with 11.3% having partial success. Total clinical success rate was 79.8%, with 18.6% achieving partial success. As a preventive measure against complications, all patients received antibiotic. Additionally, 96.8% received indomethacin suppositories, 12.1% Ringer's lactate and 12.9% pancreatic stents. The adverse effects rate was 8.8% (1.6% severe), including pancreatitis (4.8%), cholangitis (1.6%), bacteremia (0.8%) and bleeding (0.8%).
Conclusions
The results of this study show high technical and clinical success with a good safety profile. However, the histology still reveals suboptimal results Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Roig, C. A., Martin-Arranz, E., Martos, R. F., Costa, C. A., diaz, I. G., & Martin-Arranz, M. D. (2024). Cholangiopancreatoscopy SpyGlass-DS experience in a Spanish tertiary hospital. Endoscopy, 56(S 02 S 02), S61. https://doi.org/10.1055/s-0044-1782816
Vancouver
Roig CA, Martin-Arranz E, Martos RF, Costa CA, diaz IG, Martin-Arranz MD. Cholangiopancreatoscopy SpyGlass-DS experience in a Spanish tertiary hospital. Endoscopy. 2024;56(S 02 S 02):S61. doi:10.1055/s-0044-1782816
BibTeX
@article{Roig2024,
author = {Roig, C. Amiama and Martin-Arranz, E. and Martos, R. Fernandez and Costa, C. Amor and diaz, I. Gonzalez and Martin-Arranz, M. D.},
title = {Cholangiopancreatoscopy SpyGlass-DS experience in a Spanish tertiary hospital},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S61},
doi = {10.1055/s-0044-1782816}
}
EUVIMED